Difference between revisions of "Part:BBa K3610056:Design"

 
(→‎References)
 
(2 intermediate revisions by the same user not shown)
Line 8: Line 8:
 
===Design Notes===
 
===Design Notes===
 
None
 
None
−
 
−
 
  
 
===Source===
 
===Source===
Line 16: Line 14:
  
 
===References===
 
===References===
 +
Inobe, Tomonao; Nukina, Nobuyuki (2016): Rapamycin-induced oligomer formation system of FRB-FKBP fusion proteins. In: Journal of bioscience and bioengineering 122 (1), S. 40–46. DOI: 10.1016/j.jbiosc.2015.12.004.
 +
 +
Kolos, Jürgen M.; Voll, Andreas M.; Bauder, Michael; Hausch, Felix (2018): FKBP Ligands—Where We Are and Where to Go? In: Frontiers in Pharmacology 9, S. 1425. DOI: 10.3389/fphar.2018.01425.

Latest revision as of 23:27, 14 October 2020


FRB / SmallBit NanoLuc


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

None

Source

BBa_K3610023, BBa_K416001, BBa_K3168003

References

Inobe, Tomonao; Nukina, Nobuyuki (2016): Rapamycin-induced oligomer formation system of FRB-FKBP fusion proteins. In: Journal of bioscience and bioengineering 122 (1), S. 40–46. DOI: 10.1016/j.jbiosc.2015.12.004.

Kolos, Jürgen M.; Voll, Andreas M.; Bauder, Michael; Hausch, Felix (2018): FKBP Ligands—Where We Are and Where to Go? In: Frontiers in Pharmacology 9, S. 1425. DOI: 10.3389/fphar.2018.01425.